Coastlands Capital LP

This profile gathers the share dealings of Coastlands Capital LP across 3 companies, led by Adial Pharmaceuticals, Inc., Eloxx Pharmaceuticals, Inc. and Pasithea Therapeutics Corp. Over a trading history stretching from 27 May 2026 to 16 July 2026, the count stands at 7 filings.

On the market, this insider has only ever bought: 6 purchases, €139k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €15k. Scaled by market value, the purchases weigh a median 0.042% of market cap (sample: 4 purchases). The 6 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 16 July 2026 with an open-market purchase (€2,956) in Adial Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.